X

Frontiers in Oncology

Frontiers in Oncology
Correlation Between Early Endpoints and Overall Survival in Non–Small-Cell Lung Cancer

Using multiple source databases, study investigators compile a data set including 81 phase II–IV RCTs of patients with non–small-cell lung cancer.

Frontiers in Oncology
07/26/2021
Predictors for Fear of Cancer Recurrence in Breast Cancer Patients Referred to Radiation Therapy During the COVID-19 Pandemic

The outbreak of COVID-19 pandemic has greatly impacted on RT strategy for breast cancer patients, which might lead to increased distressing psychological symptoms.

Frontiers in Oncology
07/26/2021
Disease-Specific Survival of AJCC 8th Stage II Gastric Cancer Patients After D2 Gastrectomy

The purpose of this study is to investigate the independent risk factors for treatment failure in stage II gastric cancer.

Frontiers in Oncology
07/26/2021
Multi-Omic Analyses of the m5C Regulator ALYREF Reveal Its Essential Roles in Hepatocellular Carcinoma

In a pan-cancer tissue analysis that included HCC, study investigators assessed the expression of ALYREF compared to normal tissues using The Cancer Genome Atlas database.

Frontiers in Oncology
07/23/2021
Nivolumab in Non–Small-Cell Lung Cancer: Real World Long-Term Survival Results and Blood-Based Efficacy Biomarkers

Study investigators aim to examine clinical data and baseline blood test results as potential predictive biomarkers for benefit from nivolumab, in advanced non–small-cell lung cancer patients.

Frontiers in Oncology
07/21/2021
Development and External Validation of a Nomogram for Predicting Cancer-Specific Survival of Non–Small-Cell Lung Cancer Patients With Ipsilateral Pleural Dissemination

Study investigators aim to build a nomogram to predict lung cancer specific survival of NSCLC patients with ipsilateral pleural dissemination and to compare the impact of primary tumor resection...

Frontiers in Oncology
07/19/2021
Pyrotinib in the Treatment of Women With HER2-Positive Advanced Breast Cancer

This multicenter study analyzes the real-world data of women treated with pyrotinib-based therapy, aiming to describe their characteristics, treatment regimens, and to investigate...

Frontiers in Oncology
07/16/2021
Support Vector Machine Model Predicts Dose for Organs at Risk in High-Dose Rate Brachytherapy of Cervical Cancer

This study aims to establish a support vector machine model to predict the dose for organs at risk in intracavitary brachytherapy planning for cervical cancer with tandem and ovoid treatments.

Frontiers in Oncology
07/16/2021
The Basic Research of the Combinatorial Therapy of ABT-199 and Homoharringtonine on Acute Myeloid Leukemia

Study investigators examine the preclinical efficacy of a new strategy combining ABT-199 with HHT, a selective inhibitor of MCL-1 may be a promising approach for AML treatment...

Frontiers in Oncology
07/14/2021
Identification of a Three-RNA Binding Proteins Signature Predicting Prognosis for Breast Cancer

In this study, investigators focused on the communal differently expressed RBPs in four subtypes of breast cancer.

Frontiers in Oncology
07/12/2021
Subscribe to Frontiers in Oncology

source list reference

#7d60d9
#2694a4
#32a887
#85eb24
#352625
#4d4537
#d2093c
#8e3f1c
#76b6c3
#bfcfc8
#c61417
#67e25b
#efef71
#03cffc
#42fc9a
#cc529a
#c59445
#c8cc0c
#bf6be3
#e8085a
#97d1a0
#74e391
#eb6342
#b61f77
#a153ac
#e7f6e3
#6fc969
#9a8c2c
#a9c507
#2b9ab3
#e61923
#990677
#4a7bab
#89f67c
#49a21d
#2c990a
#d7da81
#f5ce42
#575662
#a60538
#49cde9
#c20fce
#d95d39
#eb5834